2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
14
Breast Neoplasms
11
Lymphoma, Non-Hodgkin
5
Neoplasms
4
Lymphoma
4
Heart Failure
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leukemia
2
Heart Diseases
2
Cardiovascular Diseases
2
Burkitt Lymphoma
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Obesity
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Mesothelioma
1
Memory Disorders
1
Interventions
Nebivolol
1
Methods
1
Exercise Therapy
1
Exercise
1
Electrocardiography
1
Echocardiography
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ventricular Dysfunction, Left
×
Echocardiography
×
Clear all
NCT05939089
2023-07-11
CASPER
Istanbul University
Completed
54 enrolled